Department Of Health, Goldshield Settlement, UK

Main Category: Pharma Industry / Biotech Industry
Also Included In: Litigation / Medical Malpractice;  Public Health
Article Date: 26 Jun 2007 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The Department of Health and Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Limited ("Goldshield") are pleased to jointly announce settlement of the claims brought against Goldshield for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs.

Under the terms of the settlement Goldshield have agreed, on a full and final basis and without admission of liability, to pay the NHS the sum of £4 million and to provide co-operation in connection with the continuing civil claims regarding the alleged price fixing arrangements. Both Goldshield and the Department of Health look forward to a strong working relationship in the future.

Department of Health, UK

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
DEPARTMENT OF HEALTH, UK. "Department Of Health, Goldshield Settlement, UK." Medical News Today. MediLexicon, Intl., 26 Jun. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/75179.php>

APA
DEPARTMENT OF HEALTH, UK. (2007, June 26). "Department Of Health, Goldshield Settlement, UK." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/75179.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »